The WHO Prequalification Unit (PQT) is introducing an electronic Common Technical Document (eCTD) submission facility through the ePQS Portal for the prequalification of medicines and vaccines.
The eCTD is an internationally harmonized electronic format for submitting regulatory information and applications to regulatory authorities. It is based on the Common Technical Document (CTD) developed by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Further information is available on the ICH website.
The introduction of eCTD is intended to simplify document lifecycle management for both applicants and PQT, while enhancing the efficiency, consistency, and transparency of the assessment process.
Applications in eCTD format must be submitted through the ePQS Portal.
To support applicants in preparing compliant eCTD dossiers, PQT provides a range of guidance documents and technical resources, accessible through the links below. Information on the practical steps for submission is available on the ePQS Portal webpage.
The Transition Timeline to eCTD
The transition to mandatory eCTD submissions will be implemented in phases. PQT is currently in Phase 1. Phase 2 will commence on 30 September 2027.
| Phase | APIMF/API-PQ Products | FPP Products | FVP Products |
|---|---|
Phase 1 Until September 29, 2027 | Companies may voluntarily submit applications for new products in eCTD format. Companies may voluntarily convert existing prequalified Product dossiers to eCTD. |
Phase 2 From 30 September 2027 | New product applications should be submitted in eCTD format. Companies are encouraged to convert existing prequalified product dossiers and APIMFs to eCTD before the start of phase 3. FPP products that are requalified during this phase will be asked to convert their dossiers to eCTD. |
Phase 3 From 1 October 2029 | All applications should be submitted in eCTD format. All legacy product and APIMF dossiers must have been converted to eCTD format. |
Dossier Conversion Guidance
Applicants should note the following principles regarding dossier conversion:
- Applications currently under assessment in a non-eCTD format should remain in that format until the assessment has been completed. Conversion should occur thereafter in accordance with the transition timeline above.
- Change applications in eCTD format cannot be submitted for products that are maintained in a non-eCTD format. The product dossier must first be converted to eCTD.
- Once a product dossier has been converted to eCTD format, all subsequent submissions for that product must be provided in eCTD format.
- Conversion of a legacy product dossier to eCTD can be initiated by submitting a Post-PQ change application under the subtype eCTD Baseline.
Validation of eCTD Submissions
Before submitting an eCTD application, WHO strongly recommends the use of an eCTD validation tool to verify compliance with applicable technical and regulatory requirements.
Applicants should ensure that the validation software used is current and regularly updated. Detailed validation reports can help identify and resolve issues before submission, thereby facilitating successful acceptance and review of the dossier.
Links
Webinars
- Implementing M1 for eCTD submissions submitted to the WHO Prequalification Unit (PQT) (recorded 21 November 2023)
Documents
| Name | Current Version | Legacy Version |
|---|---|---|
| eCTD - eCTD Submissions via the ePQS Portal | V1.1 | V1.0 |
| eCTD - WHO eCTD guidance for Industry | V1.0 | |
| eCTD - FAQ WHO PQT | 04 June 2026 | 09 February 2026 |
| eCTD - WHOPQT eCTD M1 Specification (Files-Elements-Folders) | V1.01 | V1.0 |
| eCTD - PQT Validation Criteria | V1.2 | V1.11 |
| eCTD - ePQS Related Product and Application type matrix | 18 October 2024 | 30 August 2024 |
| eCTD - Initial application documents | 18 October 2024 | 21 March 2024 |
| eCTD - WHO PQT eCTD checksums | V2.0 | V1.0 |
| eCTD - WHO PQT Technical Files | 10 May 2023 | |
| eCTD - WHO PQT Valid Values XML | 28 October 2024 | 31 August 2023 |